Envoy Medical, Inc. (COCH)
NASDAQ: COCH · IEX Real-Time Price · USD
4.400
+0.150 (3.53%)
May 1, 2024, 11:47 AM EDT - Market open
Envoy Medical Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Envoy Medical stock has a target of 6.00, which predicts an increase of 36.36% from the current stock price of 4.40.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Envoy Medical stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Lake Street | Lake Street | Strong Buy Maintains $3 → $6 | Strong Buy | Maintains | $3 → $6 | +36.36% | Apr 3, 2024 |
| Northland Capital Markets | Northland Capital Markets | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Dec 21, 2023 |
| Lake Street | Lake Street | Strong Buy Initiates $3 | Strong Buy | Initiates | $3 | -31.82% | Nov 28, 2023 |
Financial Forecast
Revenue This Year
340.00K
from 316.00K
Increased by 7.59%
Revenue Next Year
455.60K
from 340.00K
Increased by 34.00%
EPS This Year
-0.87
from -2.38
EPS Next Year
-0.93
from -0.87
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 420,000 | 672,000 | 2.9M |
| Avg | 339,997 | 455,603 | 2.9M |
| Low | 294,000 | 294,000 | 2.7M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | 32.9% | 97.6% | 545.3% |
| Avg | 7.6% | 34.0% | 526.9% |
| Low | -7.0% | -13.5% | 502.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -0.71 | -0.82 | -0.59 |
| Avg | -0.87 | -0.93 | -0.57 |
| Low | -1.06 | -1.12 | -0.55 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.